An overactive thyroid can affect your eyes, skin, nails, heart, weight, mood, and even your bones. In this video, we break ...

Viridian Therapeutics said on Tuesday its experimental thyroid eye disease drug met the main goal of a late-stage trial in chronic patients, sending its ​shares up nearly 50% before the bell. The drug ...

Among patients with autoimmune hyperthyroidism, those who use cannabis are 1.9 times more likely to develop exophthalmos — eyes that appear to bulge from the face — within 1 year of diagnosis, than ...

By Siddhi Mahatole May 5 (Reuters) - Viridian Therapeutics said on Tuesday its experimental thyroid eye disease drug met the ...

Prefer Newsweek on Google to see more of our trusted coverage when you search. Daisy Ridley has been diagnosed with Graves' disease—sparking questions about the illness and what its symptoms are. In ...

DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) today announced new pooled efficacy data from the Phase 2 and 3 clinical trials of TEPEZZA™ (teprotumumab-trbw) showing that the ...

New research suggests that progression of thyroid eye disease is not limited to the early disease period, with a number of ...

Daisy Ridley, 32, stunningly revealed this week that she has Graves’ disease. The “Star Wars” actress shared that after experiencing hot flashes, a racing heart rate, weight loss and fatigue, she was ...

Whereas earlier Phase 3 results disappointed Wall Street, new findings in people with “chronic” disease were viewed by ...

An injectable monoclonal antibody that targets the insulin-like growth factor I receptor improved proptosis in more than half ...

Viridian Therapeutics' shares rose after the company said its treatment for thyroid eye disease met its primary endpoint in a recent trial. The stock gained 58% to $22.30 in premarket trading Tuesday.